EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access

Role of HE4 in evaluation of adnexal masses and its comparison with CA125, ROMA and RMI in premenopausal women

Mini Sharma, Neeraj Kumar, Subhas Saha, Vanita Suri, G R Prasad, Radhika Srinivasan, Arnab Pal

African Health Sciences · 2025

DOI: 10.4314/ahs.v24i4.16 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift African Health Sciences, 2025. Verfasst von Mini Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Post Graduate Institute of Medical Education and Research, OBG. Hauptthemen laut MEDLINE: CA-125 Antigen, WAP Four-Disulfide Core Domain Protein 2, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer is the seventh most common cancer in women and is ranked third among gynaecological malignancies after cervical and uterine cancers. Prospective studies have failed to establish a definite screening programme based on tumour markers or ultrasonography.

Objective

To evaluate potential role of Human Epididymis protein 4 (HE4) as a biomarker for diagnosis of various ovarian malignancies in premenopausal age group, either alone or as a part of diagnostic algorithm like Risk of Malignancy Algorithm (ROMA) and to analyse if it has any advantage over Cancer Antigen 125 (CA125) or Risk of Malignancy Index (RMI).

Methods

It was an observational cross-sectional study which included 100 premenopausal women having ovarian mass and underwent surgery. The diagnostic performances of CA125, HE4, ROMA score and RMI for ovarian cancer were evaluated.

Results

Postoperative histopathology confirmed 30% (n=30) women to have malignant ovarian tumors. According to receiver operating characteristic (ROC) analysis; area under curve (AUC) was maximum for ROMA (0.791) followed by HE4 (0.784), RMI (0.750) and CA125 (0.715).

Conclusion

HE4 is not superior to CA125 but, it can be used in series or as part of diagnostic algorithm (ROMA) along with CA125 to get higher diagnostic accuracy for premenopausal women. Keywords: Adnexal mass; CA125; HE4; Ovarian neoplasms; Risk of malignancy index (RMI); Risk of malignancy algorithm (ROMA).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CA-125 AntigenWAP Four-Disulfide Core Domain Protein 2Ovarian NeoplasmsBiomarkers, TumorProteinsHumansFemaleCross-Sectional StudiesPremenopauseAdultMiddle AgedAlgorithmsROC Curve

Stichwörter der Autor:innen

Adnexal massCA125HE4Ovarian neoplasmsRisk of malignancy algorithm (ROMA)Risk of malignancy index (RMI)

Substanzen

CA-125 AntigenWAP Four-Disulfide Core Domain Protein 2WFDC2 protein, humanBiomarkers, TumorProteins

Autor:innen und Institutionen

  • Post Graduate Institute of Medical Education and Research, OBG.
  • Dr Rajendra Prasad Government Medical College.
  • Postgraduate Institute of Medical Education and Research, Chandigarh, Cytology and Gynecological Pathology.
  • Post Graduate Institute of Medical Education and Research, Biochemistry.

Zitieren

APA

Sharma, M., Kumar, N., Saha, S., Suri, V., Prasad, G. R., Srinivasan, R., & Pal, A. (2025). Role of HE4 in evaluation of adnexal masses and its comparison with CA125, ROMA and RMI in premenopausal women. African Health Sciences. https://doi.org/10.4314/ahs.v24i4.16

Vancouver

Sharma M, Kumar N, Saha S, Suri V, Prasad GR, Srinivasan R, et al. Role of HE4 in evaluation of adnexal masses and its comparison with CA125, ROMA and RMI in premenopausal women. African Health Sciences. 2025. doi:10.4314/ahs.v24i4.16

BibTeX
@article{Sharma2025,
  author = {Sharma, Mini and Kumar, Neeraj and Saha, Subhas and Suri, Vanita and Prasad, G R and Srinivasan, Radhika and Pal, Arnab},
  title = {Role of HE4 in evaluation of adnexal masses and its comparison with CA125, ROMA and RMI in premenopausal women},
  journal = {African Health Sciences},
  year = {2025},
  doi = {10.4314/ahs.v24i4.16}
}
Kostenlos starten →